Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study
- 1 October 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 29 (10) , 1860-1867
- https://doi.org/10.1097/00003246-200110000-00002
Abstract
To evaluate the effects of continuous infusion of methylene blue (MB), an inhibitor of the nitric oxide pathway, on hemodynamics and organ functions in human septic shock. Prospective, randomized, controlled, open-label, pilot study. Multidisciplinary intensive care unit of a university hospital. Twenty patients with septic shock diagnosed <24 hrs before randomization. Patients were randomized 1:1 to receive either MB (MB group, n = 10) or isotonic saline (control group, n = 10), adjunctive to conventional treatment. MB was administered as an intravenous bolus injection (2 mg/kg), followed 2 hrs later by infusion at stepwise increasing rates of 0.25, 0.5, 1, and 2 mg/kg/hr that were maintained for 1 hr each. During infusion, mean arterial pressure was maintained between 70 and 90 mm Hg, while attempting to reduce concurrent adrenergic support. Hemodynamics and organ function variables were assessed over a 24-hr period, and the survival rate at day 28 was noted. Infusion of MB prevented the stroke volume and the left-ventricular stroke work indexes from falling and increased mean arterial pressure. Compared with the control group, MB reduced the requirement for norepinephrine, epinephrine, and dopamine by as much as 87%, 81%, and 40%, respectively. Oxygen delivery remained unchanged in the MB group and decreased in the control group. MB also reduced the body temperature and the plasma concentration of nitrates/nitrites. Leukocytes and organ function variables such as bilirubin, alanine aminotransferase, urea, and creatinine were not significantly affected. Platelet count decreased in both groups. Five patients treated with MB survived vs. three patients receiving conventional treatment. In human septic shock, continuously infused MB counteracts myocardial depression, maintains oxygen transport, and reduces concurrent adrenergic support. Infusion of MB appears to have no significant adverse effects on the selected organ function variables.Keywords
This publication has 37 references indexed in Scilit:
- Methylene blue reduces lung fluid filtration during the early phase of endotoxemia in awake sheepCritical Care Medicine, 2001
- Methylene Blue Inhibits the Increase of Inducible Nitric Oxide Synthase Activity Induced by Stress and Lipopolysaccharide in the Medial Basal Hypothalamus of RatsNeuroimmunomodulation, 2000
- Biology of nitric oxide signalingCritical Care Medicine, 2000
- Involvement and dual effects of nitric oxide in septic shockInflammation Research, 1998
- Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shockCritical Care Medicine, 1995
- Methylene blue administration in septic shockCritical Care Medicine, 1995
- Effects of Methylene Blue on Blood Pressure and Reactivity to Norepinephrine in Endotoxemic RatsJournal of Cardiovascular Pharmacology, 1993
- Pathogenetic Mechanisms of Septic ShockNew England Journal of Medicine, 1993
- The Pathogenesis of SepsisAnnals of Internal Medicine, 1991
- Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitriteCanadian Journal of Physiology and Pharmacology, 1981